AusperBio Completes Patient Enrollment in Phase III AUSHINE Study of AHB-137 for Chronic Hepatitis B
AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company developing targeted oligonucleotide therapies for functional cure of chronic ...
Some scientists are hesitant to submit nonsignificant results to journals, citing reputation as a major factor.
Thales will modernise the Air Traffic Control Centre of Panama’s Civil Aviation Authority by delivering a full suite of advanced air traffic management solutions designed to improve safety, efficiency ...
Canadian national host sites, SciNet and SHARCNET standardize on the VAST AI Operating System as demand for GPU-powered ...
Background Withdrawal of prolonged nucleos(t)ide analogue (NA) treatment results in hepatitis B surface antigen (HBsAg) loss in some subjects with chronic hepatitis B (CHB), potentially revealing ...
From Unesco listings and new museums to reviving and preserving old sites, the region's people are writing their own story ...
Gilead Sciences, Inc. today announced positive topline results from the Phase 3 ARTISTRY-2 trial. The double-blind trial evaluated the treatment responses of adults with HIV who are virologically ...
This study conducts a performance evaluation of a blockchain-based Human Resource Management System (HRMS) utilizing smart contracts to enhance organizational efficiency and scalability. Despite ...
Storj has announced Production Cloud, a purpose-built platform for modern media workflows. It combines Storj’s new Global Collaboration tier of high-performance distributed object storage and Object ...
Sitting across the table from somebody to discuss their career development, responsibilities or the performance of their business unit tends to be direct and comfortable. But in a remote environment, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback